Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Century Aluminium | CENX | Mar 14, 2025 | 19.95 | +2.84 |
Century Casinos | CNTY | Mar 14, 2025 | 1.90 | -0.52 |
Century Communities | CCS | Mar 14, 2025 | 68.07 | +0.98 |
Century Therapeutics | IPSC | Mar 14, 2025 | 0.60 | +6.77 |
Ceragon Networks | CRNT | Mar 14, 2025 | 2.73 | +5.41 |
Cerence | CRNC | Mar 14, 2025 | 9.74 | +4.17 |
CeriBell | CBLL | Mar 14, 2025 | 21.03 | -1.73 |
CERo Therapeutics | CERO | Mar 14, 2025 | 1.02 | +6.23 |
Certara | CERT | Mar 14, 2025 | 10.92 | +4.70 |
Cerus | CERS | Mar 14, 2025 | 1.45 | +4.32 |
CervoMed | CRVO | Mar 14, 2025 | 6.44 | +11.23 |
CEVA | CEVA | Mar 14, 2025 | 30.85 | +3.56 |
CF Bankshares | CFBK | Mar 14, 2025 | 21.73 | +0.28 |
CF Industries | CF | Mar 14, 2025 | 76.63 | -0.25 |
CFSB Bancorp | CFSB | Mar 14, 2025 | 7.81 | +2.36 |
CG Oncology | CGON | Mar 14, 2025 | 27.80 | +7.13 |
CGI | GIB | Mar 14, 2025 | 102.97 | +2.44 |
Chain Bridge Bancorp | CBNA | Mar 14, 2025 | 22.45 | -0.04 |
Champion Homes | SKY | Mar 14, 2025 | 94.45 | +2.61 |
Champions Oncology | CSBR | Mar 14, 2025 | 9.23 | +3.82 |
ChampionX | CHX | Mar 14, 2025 | 29.37 | +3.09 |
Channel Therapeutics | CHRO | Mar 14, 2025 | 1.57 | -8.19 |
Chanson International | CHSN | Mar 14, 2025 | 0.23 | -0.94 |
ChargePoint | CHPT | Mar 14, 2025 | 0.69 | +6.65 |
Charles & Colvard | CTHR | Mar 14, 2025 | 1.00 | -0.07 |
Charles River Laboratories International | CRL | Mar 14, 2025 | 171.04 | +2.46 |
Charles Schwab | SCHW | Mar 14, 2025 | 77.11 | +4.90 |
Charlton Aria Acquisition | CHAR | Mar 14, 2025 | 10.07 | +0.09 |
Charlton Aria Acquisition Unit | CHARU | Mar 14, 2025 | 10.30 | 0.00 |
Chart Industries | GTLS-B | Mar 14, 2025 | 56.49 | +3.48 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.